skip to content »

neurosurgery

Houston, Texas

A full range of modern neurosurgical specialties and techniques are provided by top BCM neurosurgery specialists.
Department of Neurosurgery
not shown on screen

Research

Research is integral part of the Department of Neurosurgery. We have more than 6,000 square feet of well-equipped basic science laboratory space as well as facilities for clinical research.

Center for Neurosurgical Intensive Care at Ben Taub Hospital:

At least 1.4 million people sustain a traumatic brain injury each year in the U.S. TBI can cause a wide range of functional changes affecting thinking, sensation, movement, language, and/or emotions. In post-concussion/mild TBI patients, recovery time is within weeks/months, but a small percentage have persistent symptoms. Patients with moderate to severe TBI may never fully recover their pre-injury function. The Center for Neurosurgical Intensive Care, consisting of investigators from neurosurgery, anesthesiology, pathology, and psychology fields, is working to improve the acute care management of patients with severe TBI and thereby promote better recovery of neurological function.

The Houston Veteran’s Affairs Medical Center Neurosurgical Suite:

Equipped for stereotactic surgery and microelectrode recording.

NIH Supported Research:

  • Head Injury Program Project: Vascular Mechanisms of Secondary Injury after Traumatic Brain Injury
  • Role of NOS3 in the Cerebrovascular Response to Traumatic Brain Injury
  • Biomarkers of Traumatic Brain Injury
  • Neural Mechanisms of Object Recognition
  • Detection of Topoisomerase II Mediated DNA Damage in Stroke
  • Semi-Artificial Nanomachines for Detection of DNA Damage and Apoptosis

Research Laboratories and Programs:

  • Rajesh Bindal, M.D.: Minimally invasive spinal surgery techniques
  • Oliver Bogler, Ph.D.: Angiogenesis and apoptosis in gliomas
  • Cassius Bordelon, Ph.D.; Daniel Yoshor, M.D.; Bruce Ehni, M.D.: Neurosurgical anatomy cadaver laboratory
  • Robert Dauser, M.D.: Spinal regeneration
  • Vladimir Didenko, M.D., Ph.D.: Development of methods to detect and control programmed cell death, including development and application of nucleic acid-based nanoprobes, DNA-enzymes and self-assembling molecular systems
  • Amy Heimberger, M.D., Ph.D.: Glioma immunutherapy
  • Suyun Huang, Ph.D.: Molecular mechanisms of brain metastasis
  • Daniel H. Kim, M.D.: Spinal biomechanics
  • Seiji Kondo, Ph.D.: Telemorase inhibition and autophagy in gliomas
  • Frederick F. Lang, M.D.: Molecular biology of brain tumors
  • Harvey S. Levin, Ph.D.: Neuropsychology and biobehavioral statistics laboratory
  • Michael A. K. Liebschner, Ph.D.: Kinematics Bio-Design laboratory
  • Ian McCutcheon, M.D.: Growth factors in meningiomas
  • Ganesh Rao, M.D.: Murine model of medulloblastoma
  • Claudia S. Robertson, M.D.; Leela Cherian, Ph.D.; Shankar Gopinath, M.D.: Mechanisms of and interventions for primary and secondary traumatic brain injury, cerebral blood flow, ICP and metabolism in neural trauma
  • H. David Shine, Ph.D: Development of cell and gene therapy for the treatment of neuronal injury, tumor ablation and neurodegenerative disorders
  • Daniel Yoshor, M.D.: Human neurophysiology, responsive neurostimulation for intractable epilepsy
  • William Whitehead, M.D.: Hydrocephalus. Hydrocephalus Clinical Research Network

E-mail this page to a friend